UBI集團訊息
美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士 受邀在2018揚州生物醫藥論壇中專題演講
王長怡博士受邀於25日在揚州月畔灣酒店由揚州國家高新技術產業開發區舉辦的「2018揚州生物醫藥論壇」中給予專題演講。
UBI集團訊息
-
View More 
United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s DiseaseUBI集團訊息United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease
Candidates Generated with United Neuroscience Endobody Technology Will be Tested at the Center for Alzheimer’s and Neurodegenerative Diseases -
View More 
United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson’s DiseaseUBI集團訊息United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson’s Disease
Research Collaboration Focuses on United Neuroscience “Endobody" Technology Directed Against Pathogenic Forms of α-Synuclein Protein -
View More 
USC President, a US Congressman, a Nobel Laureate, United Neuroscience Executives and pioneering scientists are Amongst 2018 award recipients of Brain Mapping FoundationUBI集團訊息USC President, a US Congressman, a Nobel Laureate, United Neuroscience Executives and pioneering scientists are Amongst 2018 award recipients of Brain Mapping Foundation
Society for Brain Mapping and Therapeutics (SBMT) will hold its 15th Annual World Congress at the Millennium Biltmore Hotel in DTLA from April 13-15, 2018 including 400 speakers and 11 keynote speakers. -
View More 
United BioPharma received approval of the multi-nation, multi-center phase 3 IND from Thailand FDA for UB-421 in HAART substitution trialUBI集團訊息United BioPharma received approval of the multi-nation, multi-center phase 3 IND from Thailand FDA for UB-421 in HAART substitution trial
The approval from Thailand FDA an IND application for a multi-nation, multi-center, Phase III clinical trial with UB-421 -
View More 
聯生藥愛滋病抗體新藥UB-421多國多中心三期臨床試驗獲泰國FDA核准進行UBI集團訊息聯生藥愛滋病抗體新藥UB-421多國多中心三期臨床試驗獲泰國FDA核准進行
UB-421規劃在台灣、中國與泰國三個地區執行之多國多中心HAART取代性療法第三期臨床試驗 -
View More 聯生藥與美國奇異公司再度攜手，將於揚州打造先進單株抗體藥物生產基地
-
View More 
UBP Construction Plan to start on new facility for biopharmaceutical manufacturing in ChinaUBI集團訊息UBP Construction Plan to start on new facility for biopharmaceutical manufacturing in China
Construction will begin on a state-of-the-art biopharmaceutical manufacturing plant in China to support the development of mAb. -
-
View More 
United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental NeurotherapeuticsUBI集團訊息United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics
United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics -
View More 
United Neuroscience Announces Development Plans for Vaccine to Prevent CTEUBI集團訊息United Neuroscience Announces Development Plans for Vaccine to Prevent CTE
Vaccine to Progress from Current Animal Studies to First Clinical Study Next Year -
View More 
United Neuroscience’s Mei Mei Hu Interviewed by MSNBC’s Ali VelshiUBI集團訊息United Neuroscience’s Mei Mei Hu Interviewed by MSNBC’s Ali Velshi
United Neuroscience’s Mei Mei Hu Interviewed by MSNBC’s Ali Velshi
-
-
View More 
我們有話要說 (二)：病毒不斷突變也不怕！聯亞生技廣譜新冠疫苗可協助解決病毒變異及疫苗頻繁接種的安全與有效性！我們有話要說 (二)：病毒不斷突變也不怕！聯亞生技廣譜新冠疫苗可協助解決病毒變異及疫苗頻繁接種的安全與有效性！ -
View More 
我們有話要說 (三)：良好的保護力絕不能只看中和抗體！全球科學界大聲疾呼正視T細胞免疫記憶能力之重要性 –強力T細胞免疫才能提供免於感染各種變異病毒株的廣譜保護力–我們有話要說 (三)：良好的保護力絕不能只看中和抗體！全球科學界大聲疾呼正視T細胞免疫記憶能力之重要性 –強力T細胞免疫才能提供免於感染各種變異病毒株的廣譜保護力– -
View More 
我們有話要說(四)：聯亞生技UB-612新冠疫苗追加劑試驗數據展現強效且廣譜的的B細胞和T細胞免疫能力; 期盼政府支持UB-612加速審查，共同為國家與人民福祉創造多贏我們有話要說(四)：聯亞生技UB-612新冠疫苗追加劑試驗數據展現強效且廣譜的的B細胞和T細胞免疫能力; 期盼政府支持UB-612加速審查，共同為國家與人民福祉創造多贏
TAG相關標籤
POPULAR熱門文章
